Therapeutics Neurodegenerative diseases

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

CuraSen Therapeutics

This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.

NeuroTherapia

This clinical-stage company develops oral small-molecule therapies targeting neuroinflammation for patients with Alzheimer's disease and other neurodegenerative disorders.

Scripta Therapeutics

The company develops therapeutics that modulate transcription factor activity to treat neurodegenerative diseases for patients with conditions such as Alzheimer's and Parkinson's.

PharmatrophiX

The company develops small-molecule therapies targeting neurotrophin receptors for patients with Alzheimer's disease and other neurodegenerative disorders.

Asceneuron

The company develops oral small molecule therapies for neurodegenerative diseases including Alzheimer's and Parkinson's to treat patients suffering from chronic neurologic disorders.

Tetra Therapeutics

This biotechnology company develops therapeutic drugs for patients suffering from neurological conditions such as Alzheimer's disease and Fragile X syndrome.

Yumanity Therapeutics

This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.